RTP drugmaker raises $15M as it moves forward with potential Alzheimer’s treatment


A Triangle company looking to stop Alzheimer’s Disease has closed a sizable fundraising round to push forward its pipeline.

Previous Should you change your investments based on the current political environment?
Next Revealed: Meet the winners of the PSBJ's inaugural Health Care Leadership Awards